Objectives	To be able to describe the epidemiology, aetiology and risk factors of ovarian cancer To be able to perform specialist assessment and to develop a multidisciplinary management plan for newly diagnosed patients with ovarian cancer To be able to formulate treatment plans for patients with recurrent ovarian cancer, including palliation
Awareness	Awareness of risk factors Awareness of symptoms and signs Appreciation of the evidence for screening and preventive measures Recognition of the genetic predisposition to ovarian cancer Awareness of imaging modalities and serum markers to diagnose and manage patients with ovarian cancer Appreciation of fertility preservation options Appreciation of issues surrounding management of ovarian cancer in pregnancy Awareness of survivorship-related issues
Knowledge	Familiarity with the anatomy related to ovarian cancer Knowledge of the staging systems used in ovarian cancer Familiarity with the histological and molecular subtypes of ovarian cancer and the associated clinical behaviour Understanding of the relevance of BReast CAncer (BRCA) testing in ovarian cancer Understanding of the management of newly diagnosed (first-line) ovarian cancer: ◦ Evidence for and role of primary debulking surgery, primary chemotherapy and interval debulking surgery ◦ Evidence and indications for adjuvant systemic therapy (including antiangiogenic therapy, dose-dense and intraperitoneal chemotherapy) ◦ Surgical management: first-line, recurrent, palliative Understanding of the management of recurrent ovarian cancer: ◦ Familiarity with the relevance of treatment-free interval ◦ Platinum-sensitive, platinum-resistant and platinum-refractory (chemotherapy and targeted therapy options such as antiangiogenic therapy and poly ADP ribose polymerase (PARP) inhibitors) ◦ Role for surgery in relapsed disease, including palliative procedures, eg, in case of bowel obstruction Knowledge of an overview of the management of non-epithelial ovarian cancers and ovarian tumours, eg, sex-cord stromal ovarian tumours, borderline tumours
Skills	Ability to contribute to the multidisciplinary management decisions of patients with newly diagnosed and recurrent ovarian cancer Ability to determine and prescribe systemic therapy plans for newly diagnosed and recurrent patients with ovarian cancer, taking into consideration performance status, comorbidities and prior toxicities Ability to evaluate patients for therapy (history and physical examination, including internal) and to discuss prognosis and treatment options Ability to counsel patients regarding the relevance of BRCA gene testing Ability to assess and manage disease-related events (eg, ascites, bowel obstruction), and complications of systemic therapies Ability to discuss cancer follow-up with patients